FI971234A - Imidatsolijohdannainen - Google Patents
Imidatsolijohdannainen Download PDFInfo
- Publication number
- FI971234A FI971234A FI971234A FI971234A FI971234A FI 971234 A FI971234 A FI 971234A FI 971234 A FI971234 A FI 971234A FI 971234 A FI971234 A FI 971234A FI 971234 A FI971234 A FI 971234A
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- halogeno
- formula
- imidazole
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Dental Preparations (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25749094 | 1994-09-26 | ||
| JP8469095 | 1995-03-15 | ||
| JP22720595 | 1995-08-12 | ||
| PCT/JP1995/001936 WO1996010019A1 (fr) | 1994-09-26 | 1995-09-25 | Derive imidazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI971234A0 FI971234A0 (fi) | 1997-03-25 |
| FI971234A true FI971234A (fi) | 1997-05-23 |
Family
ID=27304632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI971234A FI971234A (fi) | 1994-09-26 | 1997-03-25 | Imidatsolijohdannainen |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5910506A (fi) |
| EP (1) | EP0786455B1 (fi) |
| JP (1) | JP3155009B2 (fi) |
| KR (1) | KR100387157B1 (fi) |
| CN (1) | CN1093535C (fi) |
| AT (1) | ATE255564T1 (fi) |
| BR (1) | BR9509024A (fi) |
| CA (1) | CA2200316C (fi) |
| DE (1) | DE69532245T2 (fi) |
| DK (1) | DK0786455T3 (fi) |
| ES (1) | ES2211917T3 (fi) |
| FI (1) | FI971234A (fi) |
| HU (1) | HUT77357A (fi) |
| MX (1) | MX9702030A (fi) |
| NO (1) | NO308739B1 (fi) |
| PL (1) | PL183931B1 (fi) |
| PT (1) | PT786455E (fi) |
| RU (1) | RU2157368C2 (fi) |
| TW (1) | TW401404B (fi) |
| WO (1) | WO1996010019A1 (fi) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997035843A1 (fr) * | 1996-03-28 | 1997-10-02 | Shionogi & Co., Ltd. | Derives d'imidazole absorbables par la lymphe |
| AU712071B2 (en) * | 1996-04-04 | 1999-10-28 | Shionogi & Co., Ltd. | Anti-HIV composition containing imidazole derivatives |
| KR100399463B1 (ko) * | 1996-12-26 | 2003-09-29 | 시오노기세이야쿠가부시키가이샤 | 이미다졸 유도체의 제조 방법 |
| ATE261944T1 (de) * | 1996-12-26 | 2004-04-15 | Shionogi & Co | Verfahren zur herstellung von carbamoylsubstituierten imidazolderivaten |
| TWI232214B (en) * | 1998-04-16 | 2005-05-11 | Shionogi & Co | Preparation of aryl sulfenyl halide |
| WO2000061109A1 (fr) | 1999-04-12 | 2000-10-19 | Shionogi & Co., Ltd. | Procede de production de composition medicamenteuse renfermant un compose medicamenteux hydrophobe basique |
| GB0016787D0 (en) | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
| KR100567706B1 (ko) | 2001-01-31 | 2006-04-05 | 워너-램버트 캄파니 엘엘씨 | 알코올의 카르바모일화 방법 |
| JP2004519477A (ja) * | 2001-02-23 | 2004-07-02 | カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント | Ｈｉｖ抑制ｎ−アミノイミダゾール誘導体 |
| DE60219292T2 (de) | 2001-04-10 | 2008-04-10 | Pfizer Inc. | Pyrazolderivate zur behandlung von hiv |
| GB0113524D0 (en) | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
| EA008775B1 (ru) | 2002-04-26 | 2007-08-31 | Джилид Сайэнс, Инк. | Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция |
| TW200423930A (en) | 2003-02-18 | 2004-11-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitors |
| JP4485520B2 (ja) | 2003-03-24 | 2010-06-23 | エフ．ホフマン−ラ ロシュ アーゲー | 逆転写酵素阻害剤としてのベンジル−ピリダジノン類 |
| DK1628685T3 (da) | 2003-04-25 | 2011-03-21 | Gilead Sciences Inc | Antivirale phosphonatanaloge |
| US7300924B2 (en) | 2003-04-25 | 2007-11-27 | Gilead Sciences, Inc. | Anti-infective phosphonate analogs |
| WO2005002626A2 (en) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Therapeutic phosphonate compounds |
| WO2004096287A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| US7470724B2 (en) | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| US7452901B2 (en) | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| JP2006524710A (ja) | 2003-04-25 | 2006-11-02 | ギリアード サイエンシーズ， インコーポレイテッド | キナーゼインヒビターホスホネート抱合体 |
| US7407965B2 (en) | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| US7432261B2 (en) | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| WO2005016912A1 (en) * | 2003-08-19 | 2005-02-24 | Pfizer Inc. | An efficient microbial preparation of capravirine metabolites m4 and m5 |
| WO2005044308A1 (en) | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| WO2005044279A1 (en) | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Purine nucleoside phosphonate conjugates |
| JP2007508843A (ja) | 2003-10-24 | 2007-04-12 | ギリアード サイエンシーズ， インコーポレイテッド | 治療用化合物の同定のための方法および組成物 |
| MXPA06006899A (es) | 2003-12-22 | 2006-09-04 | Gilead Sciences Inc | Derivados de carbovir y abacavir 4'-sustituidos asi como compuestos relacionados con actividad antiviral de virus de inmunodeficiencia humana y virus de la hepatitis c. |
| US20080132549A1 (en) * | 2004-04-14 | 2008-06-05 | Pfizer Inc. | Sulphur-Linked Imidazone Compounds for the Treatment of Hiv/Aids |
| US7871991B2 (en) | 2004-07-27 | 2011-01-18 | Gilead Sciences, Inc. | Phosphonate analogs of HIV inhibitor compounds |
| CN1993333B (zh) | 2004-08-04 | 2012-08-01 | 大正制药株式会社 | ***衍生物 |
| CA2592909A1 (en) * | 2005-01-06 | 2006-07-13 | Pfizer Limited | Imidazole derivatives as enzyme reverse transcriptase modulators |
| NZ568285A (en) * | 2005-12-01 | 2011-08-26 | Hoffmann La Roche | 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents |
| US8022091B2 (en) | 2006-02-03 | 2011-09-20 | Taisho Pharmaceutical Co., Ltd. | Triazole derivative |
| RU2395499C2 (ru) * | 2006-02-06 | 2010-07-27 | Тайсо Фармасьютикал Ко., Лтд. | Ингибитор связывания сфингозин-1-фосфата |
| US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
| US7994205B2 (en) * | 2006-03-31 | 2011-08-09 | Takeda Pharmaceutical Company Limited | Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors |
| CA2658984C (en) | 2006-08-16 | 2014-12-02 | Joshua Kennedy-Smith | Non-nucleoside reverse transcriptase inhibitors |
| WO2009017219A1 (ja) | 2007-08-01 | 2009-02-05 | Taisho Pharmaceutical Co., Ltd. | Ｓ１ｐ1結合阻害物質 |
| TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
| KR101558011B1 (ko) * | 2007-09-28 | 2015-10-06 | 다케다 야쿠힌 고교 가부시키가이샤 | 양성자 펌프 억제제로서의 5-원 이종원자고리 화합물 |
| ES2526649T3 (es) | 2007-12-21 | 2015-01-14 | F. Hoffmann-La Roche Ag | Compuestos heterocíclicos antivíricos |
| MX2011000306A (es) | 2008-07-08 | 2011-03-15 | Gilead Sciences Inc | Sales de compuestos inhibidores de hiv. |
| JP2012517479A (ja) * | 2009-02-12 | 2012-08-02 | エグゼリクシス， インコーポレイテッド | 糖尿病および肥満の処置においてｔｇｒ５アゴニストとして使用するためのトリアゾールおよびイミダゾール誘導体 |
| CA2756086A1 (en) | 2009-03-26 | 2010-09-30 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
| EP2508511A1 (en) | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| PL2890684T3 (pl) * | 2012-07-24 | 2018-08-31 | Bial-Portela & Ca, S.A. | Związki mocznikowe i ich zastosowanie jako inhibitorów enzymu |
| EP2716632A1 (en) | 2012-10-05 | 2014-04-09 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| EP2716639A1 (en) | 2012-10-05 | 2014-04-09 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| GB201602934D0 (en) | 2016-02-19 | 2016-04-06 | Cancer Res Inst Royal | Compounds |
| EP3381905A1 (en) * | 2017-03-30 | 2018-10-03 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Novel antiviral compounds |
| EP3960740B1 (en) | 2017-08-01 | 2023-11-15 | Gilead Sciences, Inc. | Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) vanillate for treating viral infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63150266A (ja) * | 1986-12-12 | 1988-06-22 | Mitsui Petrochem Ind Ltd | ベンジルイミダゾ−ル誘導体 |
| JPH0283373A (ja) * | 1988-05-19 | 1990-03-23 | Nippon Soda Co Ltd | ５員環の複素環化合物及びその製造方法 |
| IL98319A (en) * | 1990-07-05 | 1997-04-15 | Roussel Uclaf | Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them |
| TW235963B (fi) * | 1992-01-16 | 1994-12-11 | Shionogi & Co | |
| DE10230797C2 (de) * | 2001-07-16 | 2003-09-25 | Dieter Reif | Befestigungsklammer zur Verbindung von Holzbauteilen |
-
1995
- 1995-09-25 WO PCT/JP1995/001936 patent/WO1996010019A1/ja active IP Right Grant
- 1995-09-25 JP JP51159896A patent/JP3155009B2/ja not_active Expired - Fee Related
- 1995-09-25 ES ES95932231T patent/ES2211917T3/es not_active Expired - Lifetime
- 1995-09-25 AT AT95932231T patent/ATE255564T1/de not_active IP Right Cessation
- 1995-09-25 CA CA002200316A patent/CA2200316C/en not_active Expired - Fee Related
- 1995-09-25 HU HU9701899A patent/HUT77357A/hu not_active Application Discontinuation
- 1995-09-25 EP EP95932231A patent/EP0786455B1/en not_active Expired - Lifetime
- 1995-09-25 BR BR9509024A patent/BR9509024A/pt not_active IP Right Cessation
- 1995-09-25 PT PT95932231T patent/PT786455E/pt unknown
- 1995-09-25 PL PL95320009A patent/PL183931B1/pl not_active IP Right Cessation
- 1995-09-25 US US08/809,624 patent/US5910506A/en not_active Expired - Fee Related
- 1995-09-25 DE DE69532245T patent/DE69532245T2/de not_active Expired - Fee Related
- 1995-09-25 RU RU97106829/04A patent/RU2157368C2/ru not_active IP Right Cessation
- 1995-09-25 DK DK95932231T patent/DK0786455T3/da active
- 1995-09-25 KR KR1019970701989A patent/KR100387157B1/ko not_active IP Right Cessation
- 1995-09-25 CN CN95195260A patent/CN1093535C/zh not_active Expired - Fee Related
- 1995-09-25 MX MX9702030A patent/MX9702030A/es not_active IP Right Cessation
- 1995-09-29 TW TW084110183A patent/TW401404B/zh not_active IP Right Cessation
-
1997
- 1997-03-20 NO NO971306A patent/NO308739B1/no unknown
- 1997-03-25 FI FI971234A patent/FI971234A/fi unknown
-
1998
- 1998-12-04 US US09/205,289 patent/US6147097A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT786455E (pt) | 2004-02-27 |
| CN1158609A (zh) | 1997-09-03 |
| DE69532245T2 (de) | 2004-09-16 |
| EP0786455A1 (en) | 1997-07-30 |
| CA2200316A1 (en) | 1996-04-04 |
| US6147097A (en) | 2000-11-14 |
| EP0786455B1 (en) | 2003-12-03 |
| NO971306L (no) | 1997-05-21 |
| AU4788896A (en) | 1996-04-19 |
| DE69532245D1 (en) | 2004-01-15 |
| PL183931B1 (pl) | 2002-08-30 |
| AU706095B2 (en) | 1999-06-10 |
| ES2211917T3 (es) | 2004-07-16 |
| EP0786455A4 (en) | 1998-12-30 |
| US5910506A (en) | 1999-06-08 |
| DK0786455T3 (da) | 2004-03-29 |
| WO1996010019A1 (fr) | 1996-04-04 |
| HUT77357A (hu) | 1998-03-30 |
| JP3155009B2 (ja) | 2001-04-09 |
| BR9509024A (pt) | 1997-09-30 |
| RU2157368C2 (ru) | 2000-10-10 |
| CA2200316C (en) | 2004-09-21 |
| KR100387157B1 (ko) | 2003-09-29 |
| FI971234A0 (fi) | 1997-03-25 |
| NO971306D0 (no) | 1997-03-20 |
| TW401404B (en) | 2000-08-11 |
| CN1093535C (zh) | 2002-10-30 |
| NO308739B1 (no) | 2000-10-23 |
| KR970706260A (ko) | 1997-11-03 |
| PL320009A1 (en) | 1997-09-01 |
| ATE255564T1 (de) | 2003-12-15 |
| MX9702030A (es) | 1997-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0786455T3 (da) | Imidazolderivater | |
| NO179142C (no) | 3-benzyliden-1-karbamoyl-2-pyrrolidon-analoger | |
| DE69129090D1 (de) | Derivate von cyclischen Amiden | |
| ES2093091T3 (es) | Derivado de glutation. | |
| ATE113030T1 (de) | Hydroxyalkancarbonsäure-derivate und deren verwendung. | |
| DE69416683D1 (de) | Benzolactam-derivate | |
| DK0601191T3 (da) | Hidtil ukendt tetracyklisk forbindelse | |
| DK0594329T3 (da) | Antimikrobielle midler, der omfatter polykvaternære ammoniumforbindelser | |
| ATE184605T1 (de) | Methotrexat-derivate | |
| ATE318265T1 (de) | Amidin-derivate, ihre herstellung und verwendung als medikamenten | |
| ATE284379T1 (de) | Aminderivate | |
| BR9305092A (pt) | Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo | |
| ES2077697T3 (es) | Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos. |